India Maintains Status Quo On Compulsory Licensing Provisions; Indian, MNC Lobbies Welcome Moves To Keep Flexibility But Future Doubts Linger

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.